Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Ping Xiang in Alzheimer's Disease Research
Introduction
Ping Xiang is a notable inventor based in Xianyang, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for Alzheimer's disease. His work focuses on innovative chemical compounds that have the potential to improve patient outcomes.
Latest Patents
Ping Xiang holds a patent for a compound titled "3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease." This patent discloses the preparation method and application of 3,4-methylenedioxyphenylimidazolylethanonexime ether derivatives. These compounds have shown a significant effect on the inhibition of nitric oxide production, with an effective concentration (EC) of 2.07-5.41 μmol/L. Compared to the positive control group of quercetin and oxiconazole, which have higher EC values, the derivatives exhibit a stronger inhibitory effect without significant cytotoxicity, maintaining cell viability above 90%. This innovation holds promise for the development of new drugs aimed at treating Alzheimer's disease.
Career Highlights
Ping Xiang is affiliated with Northwest A&F University, where he conducts research and collaborates with fellow scientists. His work is characterized by a commitment to advancing medical science through innovative chemical research.
Collaborations
He has worked alongside colleagues such as Jiangjiang Tang and Zhaoyuan Bian, contributing to a collaborative environment that fosters innovation and discovery in the field of pharmaceutical sciences.
Conclusion
Ping Xiang's contributions to Alzheimer's disease research through his innovative patent highlight the importance of chemical advancements in medicine. His work not only showcases his expertise but also offers hope for future treatments in the fight against this debilitating condition.